Radio waves plus targeted drug tested in tough-to-treat colon cancer
NCT ID NCT07130903
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study tests whether adding a device that delivers low-level radiofrequency electromagnetic fields (AM RF EMF) to the targeted drug fruquintinib can help people with metastatic colorectal cancer live longer. The treatment is for patients whose cancer has not responded to or stopped responding to standard therapies. About 102 participants will receive the combination and be monitored for survival and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
Contact Phone: •••-•••-••••
-
Karmanos Cancer Institute at McLaren Bay Region
RECRUITINGBay City, Michigan, 48706, United States
Contact
-
Karmanos Cancer Institute at McLaren Clarkston
RECRUITINGClarkston, Michigan, 48346, United States
Contact
-
Karmanos Cancer Institute at McLaren Flint
RECRUITINGFlint, Michigan, 48532, United States
Contact
-
Karmanos Cancer Institute at McLaren Greater Lansing
RECRUITINGLansing, Michigan, 48910, United States
Contact
-
Karmanos Cancer Institute at McLaren Lapeer Region
RECRUITINGLapeer, Michigan, 48446, United States
Contact
-
Karmanos Cancer Institute at McLaren Macomb
RECRUITINGMacomb, Michigan, 48043, United States
Contact
-
Karmanos Cancer Institute at McLaren Northern Michigan, Petoskey
RECRUITINGPetoskey, Michigan, 49770, United States
Contact
-
Karmanos Cancer Institute at McLaren Port Huron
RECRUITINGPort Huron, Michigan, 48060, United States
Contact
Conditions
Explore the condition pages connected to this study.